By Tendai Chisiri
The Medicines Control Authority of Zimbabwe (MCAZ) has issued a Class II recall of Azithromycin 500mg USP Tablets, Batch Number: 24050191, manufactured by Indoco Remedies Limited, India.
The recall is due to an out-of-specification result in dissolution testing, which may affect the medicine’s effectiveness in treating bacterial infections and contribute to antimicrobial resistance.
“The Authority is committed to safeguarding public health by ensuring that all medicines available in Zimbabwe meet the required standards of quality, safety, and efficacy,” said Mr. Richard T. Rukwata, Director-General of MCAZ in a press release.
The affected batch is being recalled up to the retail level, and wholesalers, pharmacies, clinics, and hospitals are advised to quarantine the product. The public is urged to return any affected units to the pharmacy where they were purchased.
Patients who have used the product should consult their healthcare professionals for assistance. MCAZ will monitor the recall process and provide updates as necessary.
Azithromycin is an antibiotic used to treat various bacterial infections. The recall affects Batch Number: 24050191, manufactured by Indoco Remedies Limited, India.
News Sport Online 